Blesch A, Bosserhoff AK, Apfel R; et al. (1994). "Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA". Cancer Res. 54 (21): 5695–701. PMID7923218.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Bosserhoff AK, Hein R, Bogdahn U, Buettner R (1996). "Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA". J. Biol. Chem. 271 (1): 490–5. PMID8550608.CS1 maint: Multiple names: authors list (link)
Koehler MR, Bosserhoff A, von Beust G; et al. (1996). "Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.32-q13.33 by fluorescence in situ hybridization (FISH)". Genomics. 35 (1): 265–7. PMID8661134.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Stoll R, Renner C, Zweckstetter M; et al. (2001). "The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold". EMBO J. 20 (3): 340–9. doi:10.1093/emboj/20.3.340. PMID11157741.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Lougheed JC, Holton JM, Alber T; et al. (2001). "Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins". Proc. Natl. Acad. Sci. U.S.A. 98 (10): 5515–20. doi:10.1073/pnas.091601698. PMID11331761.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Lougheed JC, Domaille PJ, Handel TM (2002). "Solution structure and dynamics of melanoma inhibitory activity protein". J. Biomol. NMR. 22 (3): 211–23. PMID11991352.CS1 maint: Multiple names: authors list (link)
Hau P, Apfel R, Wiese P; et al. (2002). "Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin". Anticancer Res. 22 (2A): 577–83. PMID12014625.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Hau P, Wise P, Bosserhoff AK; et al. (2002). "Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected]". J. Invest. Dermatol. 119 (3): 562–9. doi:10.1046/j.1523-1747.2002.00501.x. PMID12230496.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID12477932.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Poser I, Golob M, Buettner R, Bosserhoff AK (2003). "Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype". Mol. Cell. Biol. 23 (8): 2991–8. PMID12665595.CS1 maint: Multiple names: authors list (link)
Callejo SA, Marshall JC, Cools-Lartigue J; et al. (2005). "Macrophage-derived soluble factor enhances melanoma inhibitory activity expression by uveal melanoma cells in vitro". Melanoma Res. 14 (2): 91–5. PMID15057037.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Marr DG, Poser I, Shellman YG; et al. (2005). "Ultraviolet radiation induces release of MIA: a new mechanism for UVR-induced progression of melanoma". Int. J. Oncol. 25 (1): 105–11. PMID15201995.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Poser I, Tatzel J, Kuphal S, Bosserhoff AK (2005). "Functional role of MIA in melanocytes and early development of melanoma". Oncogene. 23 (36): 6115–24. doi:10.1038/sj.onc.1207797. PMID15208686.CS1 maint: Multiple names: authors list (link)
Zhang Z, Henzel WJ (2005). "Signal peptide prediction based on analysis of experimentally verified cleavage sites". Protein Sci. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMID15340161.
Jachimczak P, Apfel R, Bosserhoff AK; et al. (2004). "Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques". Int. J. Cancer. 113 (1): 88–92. doi:10.1002/ijc.20549. PMID15386421.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID15489334.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Hau P, Ruemmele P, Kunz-Schughart LA; et al. (2005). "Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma". Oncol. Rep. 12 (6): 1355–64. PMID15547763.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Tatzel J, Poser I, Schroeder J, Bosserhoff AK (2005). "Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes". Pigment Cell Res. 18 (2): 92–101. doi:10.1111/j.1600-0749.2005.00212.x. PMID15760338.CS1 maint: Multiple names: authors list (link)
Aung PP, Oue N, Mitani Y; et al. (2006). "Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer". Oncogene. 25 (17): 2546–57. doi:10.1038/sj.onc.1209279. PMID16331256.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
Cao MG, Auge JM, Molina R; et al. (2007). "Melanoma inhibiting activity protein (MIA), beta-2 microglobulin and lactate dehydrogenase (LDH) in metastatic melanoma". Anticancer Res. 27 (1B): 595–9. PMID17348447.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)